Rui Feng

494 total citations
23 papers, 317 citations indexed

About

Rui Feng is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Rui Feng has authored 23 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Rui Feng's work include Cancer Immunotherapy and Biomarkers (5 papers), Ferroptosis and cancer prognosis (5 papers) and Autophagy in Disease and Therapy (3 papers). Rui Feng is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Ferroptosis and cancer prognosis (5 papers) and Autophagy in Disease and Therapy (3 papers). Rui Feng collaborates with scholars based in China, United States and United Kingdom. Rui Feng's co-authors include Brenda B. Poindexter, Judy L. Aschner, Barbara Schmidt, Anne Marie Reynolds, Roberta A. Ballard, Pamela A. Shaw, Aaron Hamvas, Alan H. Jobe, Amy C. Engevik and Michael A. Schumacher and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Frontiers in Immunology and Molecules.

In The Last Decade

Rui Feng

21 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rui Feng China 6 197 171 61 47 42 23 317
Yohei Matsuzaki Japan 8 172 0.9× 61 0.4× 87 1.4× 38 0.8× 23 0.5× 18 287
Min Rong United States 10 210 1.1× 141 0.8× 137 2.2× 34 0.7× 24 0.6× 11 339
José Alberto Rodríguez‐Castillo Germany 9 310 1.6× 201 1.2× 82 1.3× 13 0.3× 9 0.2× 10 357
Xiaoying Zhang China 10 214 1.1× 160 0.9× 110 1.8× 8 0.2× 13 0.3× 23 355
Alicia Lozano Spain 11 151 0.8× 113 0.7× 66 1.1× 160 3.4× 22 0.5× 44 388
Zhao‐Shen Li China 14 66 0.3× 297 1.7× 66 1.1× 172 3.7× 55 1.3× 42 422
Mesut Çetinkaya Türkiye 13 142 0.7× 151 0.9× 113 1.9× 33 0.7× 15 0.4× 35 437
Lea Paloheimo Finland 13 113 0.6× 225 1.3× 37 0.6× 58 1.2× 53 1.3× 25 362
Diana Treis Sweden 7 329 1.7× 20 0.1× 133 2.2× 26 0.6× 28 0.7× 13 459
Cohen Cj United States 10 42 0.2× 110 0.6× 43 0.7× 59 1.3× 36 0.9× 17 378

Countries citing papers authored by Rui Feng

Since Specialization
Citations

This map shows the geographic impact of Rui Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Feng more than expected).

Fields of papers citing papers by Rui Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Feng. The network helps show where Rui Feng may publish in the future.

Co-authorship network of co-authors of Rui Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Feng. A scholar is included among the top collaborators of Rui Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Feng. Rui Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Cheng‐Wen, Jiyong Wu, Ni Li, et al.. (2025). Advances of HDAC dual inhibitors in breast cancer treatment. Bioorganic & Medicinal Chemistry. 130. 118372–118372. 1 indexed citations
2.
3.
Yue, H., Ruixia Yang, Ziyue Wang, et al.. (2025). Efficacy and safety of first-line targeted and immunotherapy for metastatic colorectal cancer: a network meta-analysis. Frontiers in Immunology. 16. 1643133–1643133.
4.
5.
6.
Deng, Min, et al.. (2024). Comparative analysis of medical glue and positioning hooks for preoperative localization of pulmonary nodules. Frontiers in Oncology. 14. 1392213–1392213.
7.
8.
Feng, Rui, et al.. (2024). Neurotoxicity of Realgar: Crosstalk Between UBXD8-DRP1-Regulated Mitochondrial Fission and PINK1-Parkin-Mediated Mitophagy. Molecular Neurobiology. 62(6). 7041–7053. 3 indexed citations
9.
Feng, Rui, Jieyu Liu, Yang Zhao, et al.. (2023). Realgar-Induced Neurotoxicity: Crosstalk Between the Autophagic Flux and the p62-NRF2 Feedback Loop Mediates p62 Accumulation to Promote Apoptosis. Molecular Neurobiology. 60(10). 6001–6017. 4 indexed citations
10.
Feng, Rui, et al.. (2023). Identification and validation of palmitoylation metabolism-related signature for liver hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 692. 149325–149325. 4 indexed citations
11.
Liu, Jiazhou, Yuxian Wei, Rui Feng, et al.. (2023). A Ribosome-Related Prognostic Signature of Breast Cancer Subtypes Based on Changes in Breast Cancer Patients’ Immunological Activity. Medicina. 59(3). 424–424. 2 indexed citations
12.
Feng, Rui, et al.. (2023). Application of sintilimab combined with anlotinib hydrochloride in the clinical treatment of microsatellite stable colorectal cancer. World Journal of Gastrointestinal Oncology. 15(11). 1925–1935. 1 indexed citations
13.
Feng, Rui, Jiali Xu, Jing Huang, et al.. (2023). An immune-related prognostic gene ULBP2 is correlated with immunosuppressive tumor microenvironment and immunotherapy in breast cancer. Heliyon. 10(1). e23687–e23687. 6 indexed citations
14.
15.
Bai, Jing, Ping Liang, Qian Li, Rui Feng, & Jiang Liu. (2021). Cancer Immunotherapy - Immune Checkpoint Inhibitors in Hepatocellular Carcinoma. Recent Patents on Anti-Cancer Drug Discovery. 16(2). 239–248. 16 indexed citations
16.
Feng, Rui, et al.. (2021). An Autophagy-Related Gene-Based Prognostic Risk Signature for Hepatocellular Carcinoma: Construction and Validation. Computational and Mathematical Methods in Medicine. 2021. 1–11. 6 indexed citations
17.
Du, Ting, Yan Rong, Rui Feng, Alexei Verkhratsky, & Peng Liang. (2017). Chronic Treatment with Anti-bipolar Drugs Down-Regulates Gene Expression of TRPC1 in Neurones. Frontiers in Cellular Neuroscience. 10. 305–305. 4 indexed citations
18.
Poindexter, Brenda B., Rui Feng, Barbara Schmidt, et al.. (2015). Comparisons and Limitations of Current Definitions of Bronchopulmonary Dysplasia for the Prematurity and Respiratory Outcomes Program. Annals of the American Thoracic Society. 12(12). 1822–1830. 179 indexed citations
19.
Schumacher, Michael A., Rui Feng, Eitaro Aihara, et al.. (2014). Helicobacter pylori‐induced Sonic Hedgehog Expression is Regulated by NFκB Pathway Activation: The Use of a Novel In vitro Model to Study Epithelial Response to Infection. Helicobacter. 20(1). 19–28. 59 indexed citations
20.
Yan, Hongjiang, Renben Wang, Shumei Jiang, et al.. (2012). Cytokeratin 19 fragment antigen 21-1 as an independent predictor for definitive chemoradiotherapy sensitivity in esophageal squamous cell carcinoma.. PubMed. 125(8). 1410–5. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yohei Matsuzaki Breakdown of academic impact, for papers by Min Rong Breakdown of academic impact, for papers by José Alberto Rodríguez‐Castillo Breakdown of academic impact, for papers by Xiaoying Zhang Breakdown of academic impact, for papers by Alicia Lozano Breakdown of academic impact, for papers by Zhao‐Shen Li Breakdown of academic impact, for papers by Mesut Çetinkaya Breakdown of academic impact, for papers by Lea Paloheimo Breakdown of academic impact, for papers by Diana Treis Breakdown of academic impact, for papers by Cohen Cj
Rankless by CCL
2026